This document provides an overview of the history and development of Good Manufacturing Practices (GMP) regulations. It discusses key events that shaped GMP standards, including unsanitary meat packing conditions exposed in 1905, the sulfathiazole tablet contamination incident in 1941 that resulted in the formal adoption of GMP, and other drug and medical device issues in subsequent decades. The document also outlines GMP requirements regarding facilities, equipment, personnel, sanitation, materials testing, manufacturing controls, quality control, records, and other areas. Overall, it traces how GMP evolved from early 1900s to modern standards to ensure consistency and quality in pharmaceutical manufacturing.
I am uploading this GMP presentation to make aware who are working in pharma and help to maintain high standards in products manufacturing .
GMP Vs cGMP: It is my understanding that , Ultimately GMP & cGMP both the aim is same, means to prevention of the product from bad quality entering the market to endover peoples's life.
GMP applies to pharmaceutical and healthcare products and help to maintain high standards in these products.
cGMP is to remind accepting countries that all guidelines must be followed with latest and current production processes i.e employ technologies and systems which are up-to-date in order to comply with the regulation.
FDA (Food and Drug Administration) included the word “current” to ensure that regulated firms use the most current Good Manufacturing Practices (I believe that some firms would actually use outdated versions of the GMP’s to manufacture regulated products.
(the FDA have made their standards immediately identifiable i.e cGMP; Other international bodies such as the ICH, WHO use the term GMP, as do Canada, Japan and the EMEA (European authority). In FDA view cGMP means following 21 CFR 210 and 211 and no other.)
Common ways to avoid frequent gmp errorsKiran Kota
Presentation on avoiding the GMP errors with some controls and actions which are mentioned in the same which may help the industry on current trends of regulatory inspections.
The document outlines various control measures and procedures for food production facilities including personnel hygiene, facility requirements, storage practices, sanitation processes, equipment standards, and documentation. Key areas addressed are restricting access to pests, maintaining clean walls and ceilings without cracks, separating manufacturing and storage areas with controlled access, ensuring clean ceilings, walls and equipment, and proper temperature monitoring, storage, inspection of ingredients and materials. Documentation requirements include batch records, lot traceability, complaint records and sample retention.
Personal Hygiene for pharma industry-Dr. A. AmsavelDr. Amsavel A
Personal hygiene
Source of Contamination and control
GMP Requirement /Guideline
Procedures & Records
Protective Clothing & gowning
Health Examination
Hand wash – How and when
Training & Practice
by Dr. A. Amsavel
This document provides an introduction and overview of Good Manufacturing Practices (GMPs). It discusses the history and importance of GMPs in ensuring drug safety. GMPs are regulations followed by pharmaceutical companies and enforced by government agencies to ensure consistency and quality in manufacturing. The document outlines the key aspects of GMPs, including requirements for facilities, equipment, personnel, sanitation, materials testing, manufacturing controls, quality control, documentation, and specific rules for sterile products.
Auditing of capsule, sterile production and packaging MittalRohit2
The document discusses vendor audits, supplier audits, and audits of sterile product manufacturing facilities. It provides information on:
- The purpose of vendor and supplier audits to assess compliance and reduce costs.
- Key areas evaluated in vendor audits like management responsibility and data integrity.
- Benefits of audits like cost savings, process improvements, and risk reduction.
- Elements of a supplier audit checklist like infrastructure, traceability, and regulatory compliance.
- Additional controls needed for sterile product manufacturing like clean rooms, air filtration, and environmental monitoring.
- Areas examined in audits of sterile facilities including equipment validation, personnel training, and media fill programs.
GMP aims to ensure quality, safety and efficacy of medicines by requiring manufacturers to follow quality standards and comply with marketing authorizations. Inspections verify compliance and identify any deviations between dossiers and actual practices. Quality assurance, GMP, quality control, and quality risk management are interrelated aspects of quality management that are important for producing pharmaceuticals to the required standards.
This document provides an overview of a training on good manufacturing practices (GMP) for active pharmaceutical ingredients (APIs). The training will cover quality management, personnel, facilities, equipment, documentation, production, validation, laboratory control, stability testing, contract manufacturing, and agents/brokers. It discusses the introduction and scope of GMP guidelines for APIs. Key points include ensuring APIs meet quality and purity standards, applying GMP from receipt of starting materials through packaging and distribution, and the responsibilities of quality units.
I am uploading this GMP presentation to make aware who are working in pharma and help to maintain high standards in products manufacturing .
GMP Vs cGMP: It is my understanding that , Ultimately GMP & cGMP both the aim is same, means to prevention of the product from bad quality entering the market to endover peoples's life.
GMP applies to pharmaceutical and healthcare products and help to maintain high standards in these products.
cGMP is to remind accepting countries that all guidelines must be followed with latest and current production processes i.e employ technologies and systems which are up-to-date in order to comply with the regulation.
FDA (Food and Drug Administration) included the word “current” to ensure that regulated firms use the most current Good Manufacturing Practices (I believe that some firms would actually use outdated versions of the GMP’s to manufacture regulated products.
(the FDA have made their standards immediately identifiable i.e cGMP; Other international bodies such as the ICH, WHO use the term GMP, as do Canada, Japan and the EMEA (European authority). In FDA view cGMP means following 21 CFR 210 and 211 and no other.)
Common ways to avoid frequent gmp errorsKiran Kota
Presentation on avoiding the GMP errors with some controls and actions which are mentioned in the same which may help the industry on current trends of regulatory inspections.
The document outlines various control measures and procedures for food production facilities including personnel hygiene, facility requirements, storage practices, sanitation processes, equipment standards, and documentation. Key areas addressed are restricting access to pests, maintaining clean walls and ceilings without cracks, separating manufacturing and storage areas with controlled access, ensuring clean ceilings, walls and equipment, and proper temperature monitoring, storage, inspection of ingredients and materials. Documentation requirements include batch records, lot traceability, complaint records and sample retention.
Personal Hygiene for pharma industry-Dr. A. AmsavelDr. Amsavel A
Personal hygiene
Source of Contamination and control
GMP Requirement /Guideline
Procedures & Records
Protective Clothing & gowning
Health Examination
Hand wash – How and when
Training & Practice
by Dr. A. Amsavel
This document provides an introduction and overview of Good Manufacturing Practices (GMPs). It discusses the history and importance of GMPs in ensuring drug safety. GMPs are regulations followed by pharmaceutical companies and enforced by government agencies to ensure consistency and quality in manufacturing. The document outlines the key aspects of GMPs, including requirements for facilities, equipment, personnel, sanitation, materials testing, manufacturing controls, quality control, documentation, and specific rules for sterile products.
Auditing of capsule, sterile production and packaging MittalRohit2
The document discusses vendor audits, supplier audits, and audits of sterile product manufacturing facilities. It provides information on:
- The purpose of vendor and supplier audits to assess compliance and reduce costs.
- Key areas evaluated in vendor audits like management responsibility and data integrity.
- Benefits of audits like cost savings, process improvements, and risk reduction.
- Elements of a supplier audit checklist like infrastructure, traceability, and regulatory compliance.
- Additional controls needed for sterile product manufacturing like clean rooms, air filtration, and environmental monitoring.
- Areas examined in audits of sterile facilities including equipment validation, personnel training, and media fill programs.
GMP aims to ensure quality, safety and efficacy of medicines by requiring manufacturers to follow quality standards and comply with marketing authorizations. Inspections verify compliance and identify any deviations between dossiers and actual practices. Quality assurance, GMP, quality control, and quality risk management are interrelated aspects of quality management that are important for producing pharmaceuticals to the required standards.
This document provides an overview of a training on good manufacturing practices (GMP) for active pharmaceutical ingredients (APIs). The training will cover quality management, personnel, facilities, equipment, documentation, production, validation, laboratory control, stability testing, contract manufacturing, and agents/brokers. It discusses the introduction and scope of GMP guidelines for APIs. Key points include ensuring APIs meet quality and purity standards, applying GMP from receipt of starting materials through packaging and distribution, and the responsibilities of quality units.
In this presentation from Validation Week Europe, Karen Ginsbury discusses the rigors, preparations, strategies, and the do's and the don't of the FDA Inspection process.
The document discusses Good Manufacturing Practices (GMP) and contamination prevention. It covers types of contamination, sources, and how to prevent them through practices like personal hygiene, sanitation, cleaning, and equipment maintenance. GMP regulations require facilities, equipment, personnel training, and documentation to help assure product quality and safety.
Good manufacturing practices (gmp) Akash Saini (Dr. H. S. Gour University, Sa...Akash Saini
This document discusses Good Manufacturing Practices (GMP) which are procedures and processes used in manufacturing to ensure quality products. GMP covers all aspects of production from facilities and equipment to purchasing, personnel and documentation practices. It aims to minimize risks like contamination through validated processes, qualified personnel and compliance with standards. Key aspects of GMP include premises, equipment, personnel, documentation, quality control, self-inspection and auditing. GMP ensures that pharmaceutical products are consistently produced and controlled according to quality standards.
c gmp (current good manufacturing practices)Rohit K.
cGMP (Current Good Manufacturing Practices) regulations provide the framework for ensuring quality control during pharmaceutical manufacturing. The regulations are divided into parts 210 and 211. Part 211 addresses good manufacturing practices for finished pharmaceuticals and is further divided into 11 subparts covering organization, facilities, equipment, production, packaging, labeling, quality control, and more. The goal of cGMP is to ensure identity, strength, quality and purity of drugs through strict control of manufacturing and monitoring.
CGMP (Current Good Manufacturing Practices) ensures that medicinal products are consistently produced and controlled to quality standards required for their intended use. QA plays an important role in CGMP by verifying equipment qualifications, approving manufacturing documents, and verifying processes like cleaning validation, data integrity, sampling, and analytical reports. Maintaining CGMP requires following written procedures, accurately recording work, validating processes, developing facilities and equipment properly, maintaining quality control through practices like hygiene, and designing quality into manufacturing processes and product life cycles.
Ian's basic principles of gmp training presentationIan Timm
This document outlines basic principles of good manufacturing practices (GMP) for sanitation and hygiene, personal hygiene, premises cleaning, and maintenance. Some key points include: washing hands frequently and properly, not allowing illness or lesions in production areas, wearing protective clothing, prohibiting smoking/eating/drinking in production areas, conducting regular cleaning and maintenance, and completing cleaning records. Visitors, contractors and all employees must follow these hygiene procedures to prevent product contamination.
This document discusses pharmaceutical quality audits. It begins by defining quality audits and their purpose in verifying quality management systems and identifying areas for improvement. It then describes the three main types of quality audits: internal audits conducted within a company, external audits conducted by customers on suppliers, and regulatory audits conducted by independent bodies. The document outlines the objectives, management, responsibilities, planning process, information gathering techniques, administration, and classification of deficiencies for quality audits. It concludes that quality audits can benefit companies by evaluating quality systems and determining if processes and products meet requirements.
I. This document outlines the key aspects of Good Manufacturing Practices (GMP) and cGMP, including a timeline of GMP development, requirements for personnel, premises, equipment, standard operating procedures, validation processes, and documentation such as batch records.
II. It defines GMP as ensuring consistent and controlled production of products according to quality standards. cGMP requirements include qualified personnel, designed facilities and equipment, and documented procedures for manufacturing, testing, and record keeping.
III. The document provides details on specific GMP rules for premises, equipment, personnel, operations, warehousing, validation, and labeling. Adherence to GMP aims to minimize errors and ensure uniform, high quality batches of pharmaceutical products.
History of GMP and Various GMP Regulations.
Introduction to cGMP
Why GMP is so important?
Schedule M and 21 CFR Part 211
Principles of Quality
Golden Rules of cGMP
How to sustain GMP compliance?
This procedure have been established to prevent mix-ups of Empty container, component, labels, documents and mistakes while preparing or processing a product during the time of job change.
This document discusses deviations and out-of-specification/out-of-trend results in the pharmaceutical industry. It defines deviations as unwanted events that differ from approved processes or standards. Deviations are classified as major, critical, or minor depending on their impact. Out-of-specification results occur when test results fall outside predetermined specifications, requiring investigation. Out-of-trend results differ from historical results but are still within specifications, also necessitating investigation. The document provides examples of planned and unplanned deviations as well as approaches to minimize out-of-specification results through good practices.
cGMP Guidelines According to Schedule MANKUSH JADHAV
This document provides an overview of cGMP guidelines according to Schedule M. It defines cGMP and outlines key areas that must be addressed including personnel, premises, equipment, standard operating procedures, raw materials, self inspections, master formula records, batch manufacturing records, warehousing, and validation. The guidelines ensure quality products are consistently produced and that quality is built into every step of the manufacturing process.
This document provides an overview of facility design considerations for advanced sterile product manufacturing. It discusses key areas like area planning based on product type, facility classification, environmental control zones, wall and floor treatments, change rooms, personnel flow, and utility locations. Proper facility design with controlled environments and aseptic practices is necessary to ensure sterility of pharmaceutical products like APIs, antibiotics, and biological products during manufacturing.
What your organization should do and should not do during a FDA audit or inspection. For more information go go http://compliance-insight.com/fda-483-warning-letters/fda-483-inspection/
Good Documentation Practice is important to ensure activities are properly documented. GDP defines documents as instructions that guide how activities are executed, while records provide evidence activities were performed. Documentation must be accurate, concise, legible, traceable, contemporaneous, enduring and accessible. It is important to never falsify, obliterate or improperly correct information in records. All activities should be fully documented at the time they are performed. Reviews are necessary to check for completeness and compliance. Maintaining proper documentation is important for regulatory compliance, building confidence, meeting requirements, and solving problems.
Auditing of vendors and production departmentArpitSuralkar
This document outlines procedures for auditing vendors that produce capsules and sterile products. It discusses the benefits of vendor audits such as cost savings, process improvements, and risk reduction. The document describes the vendor selection process and provides a checklist for auditing vendors, which includes evaluating their premises, personnel, documentation, validation procedures, samples, stability studies, and drug recall processes. The goal of vendor audits is to inspect vendors' quality management systems and ensure they meet requirements for producing capsules and sterile medical products.
The document discusses Good Manufacturing Practices (GMP) guidelines according to ICH Q7A. It states that both GMP and cGMP aim to prevent bad quality products from entering the market. GMP applies to pharmaceutical and healthcare products, while cGMP refers to using the most up-to-date production processes and technologies to comply with regulations, as defined by the FDA. Regulatory agencies that establish GMP standards are mentioned, along with the objectives of GMP and specific guidelines covering quality management, personnel, facilities, equipment, documentation, and production records.
This document provides an overview of key elements and basic principles of Good Manufacturing Practices (GMP). It defines GMP and cGMP, outlines their importance in ensuring product quality and safety, and describes characteristics of GMP-compliant products. The document also summarizes key elements of GMP like personnel, premises, equipment, materials, and quality control. It emphasizes the importance of documentation, validation, recalls, self-inspection, storage and training in adhering to GMP. The objectives of GMP and guidelines from various regulatory bodies are also briefly mentioned.
The document outlines good manufacturing practices (GMP) that must be followed to produce safe products. It discusses personnel hygiene practices, facility requirements, storage practices, process equipment guidelines, cleaning and sanitation procedures, pest control measures, and documentation standards that are necessary to ensure product quality and safety.
The document discusses quality management systems and the six system inspection model used by the FDA to ensure compliance with cGMP regulations. It describes each of the six systems - quality system, production system, facilities and equipment system, laboratory control system, materials system, and packaging and labeling system. For each system, it provides an overview and lists the relevant cGMP subparts that govern inspections of that system. The goal is to help pharmaceutical manufacturers implement quality systems to meet FDA requirements.
This document discusses good manufacturing practices for manufacturing operations and controls in the pharmaceutical industry. It covers several key topics:
1. Sanitation of manufacturing premises is important to ensure good hygiene of facilities, equipment, processes, and personnel. Cleaning and validation procedures should be established and records maintained.
2. Proper controls must be established to prevent mix-ups and cross-contamination during production. This includes separation of products, labeling, cleaning procedures, and qualified personnel.
3. Waste and scrap from manufacturing must be properly handled, collected, stored, and disposed of according to established guidelines. Hazardous and pharmaceutical wastes require special treatment and disposal.
GOOD MANUFACTURING PRACTICES AND QUALITY ASSURANCE.pdfpoornima335163
This document provides an overview of Good Manufacturing Practices (GMP), Quality Assurance, and documentation as it relates to the pharmaceutical industry. It discusses the basic concepts of GMP including ensuring quality is built into every stage of manufacturing. It also covers the various aspects regulated by GMP such as personnel, facilities, equipment, materials, and waste disposal. Finally, it emphasizes the importance of documentation to ensure proper procedures are consistently followed.
In this presentation from Validation Week Europe, Karen Ginsbury discusses the rigors, preparations, strategies, and the do's and the don't of the FDA Inspection process.
The document discusses Good Manufacturing Practices (GMP) and contamination prevention. It covers types of contamination, sources, and how to prevent them through practices like personal hygiene, sanitation, cleaning, and equipment maintenance. GMP regulations require facilities, equipment, personnel training, and documentation to help assure product quality and safety.
Good manufacturing practices (gmp) Akash Saini (Dr. H. S. Gour University, Sa...Akash Saini
This document discusses Good Manufacturing Practices (GMP) which are procedures and processes used in manufacturing to ensure quality products. GMP covers all aspects of production from facilities and equipment to purchasing, personnel and documentation practices. It aims to minimize risks like contamination through validated processes, qualified personnel and compliance with standards. Key aspects of GMP include premises, equipment, personnel, documentation, quality control, self-inspection and auditing. GMP ensures that pharmaceutical products are consistently produced and controlled according to quality standards.
c gmp (current good manufacturing practices)Rohit K.
cGMP (Current Good Manufacturing Practices) regulations provide the framework for ensuring quality control during pharmaceutical manufacturing. The regulations are divided into parts 210 and 211. Part 211 addresses good manufacturing practices for finished pharmaceuticals and is further divided into 11 subparts covering organization, facilities, equipment, production, packaging, labeling, quality control, and more. The goal of cGMP is to ensure identity, strength, quality and purity of drugs through strict control of manufacturing and monitoring.
CGMP (Current Good Manufacturing Practices) ensures that medicinal products are consistently produced and controlled to quality standards required for their intended use. QA plays an important role in CGMP by verifying equipment qualifications, approving manufacturing documents, and verifying processes like cleaning validation, data integrity, sampling, and analytical reports. Maintaining CGMP requires following written procedures, accurately recording work, validating processes, developing facilities and equipment properly, maintaining quality control through practices like hygiene, and designing quality into manufacturing processes and product life cycles.
Ian's basic principles of gmp training presentationIan Timm
This document outlines basic principles of good manufacturing practices (GMP) for sanitation and hygiene, personal hygiene, premises cleaning, and maintenance. Some key points include: washing hands frequently and properly, not allowing illness or lesions in production areas, wearing protective clothing, prohibiting smoking/eating/drinking in production areas, conducting regular cleaning and maintenance, and completing cleaning records. Visitors, contractors and all employees must follow these hygiene procedures to prevent product contamination.
This document discusses pharmaceutical quality audits. It begins by defining quality audits and their purpose in verifying quality management systems and identifying areas for improvement. It then describes the three main types of quality audits: internal audits conducted within a company, external audits conducted by customers on suppliers, and regulatory audits conducted by independent bodies. The document outlines the objectives, management, responsibilities, planning process, information gathering techniques, administration, and classification of deficiencies for quality audits. It concludes that quality audits can benefit companies by evaluating quality systems and determining if processes and products meet requirements.
I. This document outlines the key aspects of Good Manufacturing Practices (GMP) and cGMP, including a timeline of GMP development, requirements for personnel, premises, equipment, standard operating procedures, validation processes, and documentation such as batch records.
II. It defines GMP as ensuring consistent and controlled production of products according to quality standards. cGMP requirements include qualified personnel, designed facilities and equipment, and documented procedures for manufacturing, testing, and record keeping.
III. The document provides details on specific GMP rules for premises, equipment, personnel, operations, warehousing, validation, and labeling. Adherence to GMP aims to minimize errors and ensure uniform, high quality batches of pharmaceutical products.
History of GMP and Various GMP Regulations.
Introduction to cGMP
Why GMP is so important?
Schedule M and 21 CFR Part 211
Principles of Quality
Golden Rules of cGMP
How to sustain GMP compliance?
This procedure have been established to prevent mix-ups of Empty container, component, labels, documents and mistakes while preparing or processing a product during the time of job change.
This document discusses deviations and out-of-specification/out-of-trend results in the pharmaceutical industry. It defines deviations as unwanted events that differ from approved processes or standards. Deviations are classified as major, critical, or minor depending on their impact. Out-of-specification results occur when test results fall outside predetermined specifications, requiring investigation. Out-of-trend results differ from historical results but are still within specifications, also necessitating investigation. The document provides examples of planned and unplanned deviations as well as approaches to minimize out-of-specification results through good practices.
cGMP Guidelines According to Schedule MANKUSH JADHAV
This document provides an overview of cGMP guidelines according to Schedule M. It defines cGMP and outlines key areas that must be addressed including personnel, premises, equipment, standard operating procedures, raw materials, self inspections, master formula records, batch manufacturing records, warehousing, and validation. The guidelines ensure quality products are consistently produced and that quality is built into every step of the manufacturing process.
This document provides an overview of facility design considerations for advanced sterile product manufacturing. It discusses key areas like area planning based on product type, facility classification, environmental control zones, wall and floor treatments, change rooms, personnel flow, and utility locations. Proper facility design with controlled environments and aseptic practices is necessary to ensure sterility of pharmaceutical products like APIs, antibiotics, and biological products during manufacturing.
What your organization should do and should not do during a FDA audit or inspection. For more information go go http://compliance-insight.com/fda-483-warning-letters/fda-483-inspection/
Good Documentation Practice is important to ensure activities are properly documented. GDP defines documents as instructions that guide how activities are executed, while records provide evidence activities were performed. Documentation must be accurate, concise, legible, traceable, contemporaneous, enduring and accessible. It is important to never falsify, obliterate or improperly correct information in records. All activities should be fully documented at the time they are performed. Reviews are necessary to check for completeness and compliance. Maintaining proper documentation is important for regulatory compliance, building confidence, meeting requirements, and solving problems.
Auditing of vendors and production departmentArpitSuralkar
This document outlines procedures for auditing vendors that produce capsules and sterile products. It discusses the benefits of vendor audits such as cost savings, process improvements, and risk reduction. The document describes the vendor selection process and provides a checklist for auditing vendors, which includes evaluating their premises, personnel, documentation, validation procedures, samples, stability studies, and drug recall processes. The goal of vendor audits is to inspect vendors' quality management systems and ensure they meet requirements for producing capsules and sterile medical products.
The document discusses Good Manufacturing Practices (GMP) guidelines according to ICH Q7A. It states that both GMP and cGMP aim to prevent bad quality products from entering the market. GMP applies to pharmaceutical and healthcare products, while cGMP refers to using the most up-to-date production processes and technologies to comply with regulations, as defined by the FDA. Regulatory agencies that establish GMP standards are mentioned, along with the objectives of GMP and specific guidelines covering quality management, personnel, facilities, equipment, documentation, and production records.
This document provides an overview of key elements and basic principles of Good Manufacturing Practices (GMP). It defines GMP and cGMP, outlines their importance in ensuring product quality and safety, and describes characteristics of GMP-compliant products. The document also summarizes key elements of GMP like personnel, premises, equipment, materials, and quality control. It emphasizes the importance of documentation, validation, recalls, self-inspection, storage and training in adhering to GMP. The objectives of GMP and guidelines from various regulatory bodies are also briefly mentioned.
The document outlines good manufacturing practices (GMP) that must be followed to produce safe products. It discusses personnel hygiene practices, facility requirements, storage practices, process equipment guidelines, cleaning and sanitation procedures, pest control measures, and documentation standards that are necessary to ensure product quality and safety.
The document discusses quality management systems and the six system inspection model used by the FDA to ensure compliance with cGMP regulations. It describes each of the six systems - quality system, production system, facilities and equipment system, laboratory control system, materials system, and packaging and labeling system. For each system, it provides an overview and lists the relevant cGMP subparts that govern inspections of that system. The goal is to help pharmaceutical manufacturers implement quality systems to meet FDA requirements.
This document discusses good manufacturing practices for manufacturing operations and controls in the pharmaceutical industry. It covers several key topics:
1. Sanitation of manufacturing premises is important to ensure good hygiene of facilities, equipment, processes, and personnel. Cleaning and validation procedures should be established and records maintained.
2. Proper controls must be established to prevent mix-ups and cross-contamination during production. This includes separation of products, labeling, cleaning procedures, and qualified personnel.
3. Waste and scrap from manufacturing must be properly handled, collected, stored, and disposed of according to established guidelines. Hazardous and pharmaceutical wastes require special treatment and disposal.
GOOD MANUFACTURING PRACTICES AND QUALITY ASSURANCE.pdfpoornima335163
This document provides an overview of Good Manufacturing Practices (GMP), Quality Assurance, and documentation as it relates to the pharmaceutical industry. It discusses the basic concepts of GMP including ensuring quality is built into every stage of manufacturing. It also covers the various aspects regulated by GMP such as personnel, facilities, equipment, materials, and waste disposal. Finally, it emphasizes the importance of documentation to ensure proper procedures are consistently followed.
This document discusses Good Manufacturing Practices (GMPs) in food processing. It covers several key areas:
1. The introduction outlines the development of GMPs due to commercial and legislative pressures to ensure quality and safety.
2. Buildings and facilities are important to prevent contamination and must be properly designed, constructed, and maintained. This includes considerations for grounds, plant construction, sanitary operations, and sanitary facilities.
3. Microbiological, chemical, and physical hazards are addressed through controls like hygienic practices, effective cleaning and sanitation procedures, environmental monitoring, supplier controls, and recall systems.
Good Manufacturing Practices.
Basic rules of GMP
Various aspects of GMP.
How do GMP change.
Comparison of GMP.
Quality assurance
Principles of QA
Functions of QA department.
Documentation
Importance of documentation of records
Important areas of documentation
Components of documentation
This document provides an overview of Good Manufacturing Practices (GMPs) and Hazard Analysis Critical Control Points (HACCP) programs. It discusses how GMPs and HACCP were developed to ensure food safety, the benefits of implementing these programs, and key aspects of GMPs including prerequisite programs, hazards analysis, and controlling biological, chemical and physical hazards. The summary focuses on establishing food safety programs and controlling hazards at various stages of food production.
This document discusses mercury contamination in healthcare facilities and provides guidelines for mercury elimination. It notes that mercury can be found in medical instruments, laboratory equipment, and cleaning solutions. It outlines the dangers of mercury, including toxicity and environmental contamination. The document then provides recommendations for facilities to gradually phase out mercury-containing products through education, purchasing policies, spill response procedures, and proper storage and disposal of remaining mercury devices. The overall goal is to ensure safety and prevent further mercury release into the environment.
Our company is committed to developing and implementing Good Manufacturing Practices (GMPs) following the principles of Hazard Analysis Critical Control Point (HACCP). GMPs and HACCP programs help control food safety hazards through prerequisite programs and establishing critical control points. An effective GMP/HACCP program requires commitment from both management and employees.
The document discusses food safety practices and Good Manufacturing Practices (GMPs). It covers topics like basic food safety, food handling practices, GMPs, and employee hygiene. The key points are:
1) Food safety aims to prevent foodborne illness during handling, preparation, and storage of food. Proper hygiene and sanitation standards are important.
2) GMPs are activities and practices that prevent hazards and contamination in food production. They address issues like personnel hygiene, facilities, equipment cleaning, and receiving/storage.
3) Employee hygiene practices include proper protective attire, handwashing, illness reporting, and ensuring cuts/wounds are covered. Personnel must
The document provides an overview of basic food safety practices, Good Manufacturing Practices (cGMP), and food handling procedures. It discusses key principles like preventing contamination, separating raw and cooked foods, proper cooking temperatures, and food storage temperatures. The document also outlines specific cGMP guidelines for facilities, equipment, employee hygiene, sanitation, pest control, receiving/storage areas, and maintenance/repairs to prevent food contamination.
The document discusses food safety practices and Good Manufacturing Practices (GMPs). It covers topics like basic food safety, food handling practices, GMPs, and employee hygiene. The key points are:
1) Food safety aims to prevent foodborne illness during handling, preparation, and storage of food. Proper hygiene and sanitation standards are important.
2) GMPs are activities and practices that prevent hazards and contamination in food production. This includes employee hygiene, facility maintenance, sanitation procedures, and proper receiving and storage of raw materials.
3) Employee hygiene practices like handwashing, clothing standards, and illness reporting are critical to prevent food contamination from people. Maint
gmp is the most important topic for the students of ayurveda specially for rasashstra.
so in my presentations knowledge of gmp given very elaborately and easy to understand manner.
please advise any suggestions. thank u
Personnel hygiene/ Personal hygiene and it's efficiencyArghya Chaudhuri
Hygiene is needed in an organization such as a plant or a factory. All the way from manual to Mechanized processes and Employers' roles. Discussed all the way up to hygiene efficiency.
The document provides guidelines from the World Health Organization (WHO) on various topics related to drug regulation and clinical trials. It discusses WHO's role in setting global health standards and guidelines for good manufacturing practices, stability testing, sampling, interchangeability of medicines, and clinical trial conduct. It also describes WHO resources like databases and a model system for computer-assisted drug registration.
CLEAN, SAFE SPICES
Guidance from the American Spice Trade Association
Many spices are grown in developing countries where sanitation and food handling practices may not be adequate. Agricultural products such as spices are commonly exposed to dust, dirt, insects, and animal waste before they are even harvested.
U.S. ASTA produced this guidance document to assist the spice industry in developing programs that minimize risk for contamination during growing, harvesting, drying, transport, processing, and post-processing storage, helping industry firms to provide clean, safe spices to their industrial, food service and consumer customers.
The guidance includes five key recommendations.
Detecting physical contaminants in food, such as metal, glass, stone, plastic, and bone is like trying to find a needle in a haystack, especially when the contaminant may be as small as 1 mm in diameter. Metal detectors and X-ray detection systems provide the highest sensitivity so you can find virtually any foreign object in your packaged food products. Learn about the regulations, technology, and equipment for package product quality inspection in the food industry.
More: https://www.thermofisher.com/us/en/home/industrial/food-beverage/food-weighing-inspection.html
The document outlines Good Manufacturing Practice (GMP) requirements for herbal medicines under the Drugs and Cosmetics Act in India. It discusses that herbal drugs are regulated under this Act and rules. The key GMP requirements include proper factory premises, water supply, container cleaning, health and hygiene of workers, machinery, batch manufacturing records, distribution records, and quality control. The manufacturing facilities must meet standards for location, buildings, equipment, and maintain appropriate documentation.
This document provides an overview of Good Manufacturing Practices (GMP) and Hazard Analysis and Critical Control Points (HACCP). It discusses the importance of GMP programs before implementing HACCP to control food safety hazards. General employee hygiene practices and policies to prevent contamination during food handling are outlined. Proper cleaning, sanitation, pest control, equipment handling, and food storage procedures are described to minimize risks to food safety.
MATERIAL MANAGEMENT QUALITY ASSURANCE TECHNIQUESalmanLatif14
The document discusses material management in the pharmaceutical industry. It covers various topics related to material management including definitions, objectives, purchasing, storage, and handling of raw materials, packaging materials, intermediates, rejected materials, and other item types. Proper documentation, labeling, storage conditions, and quality control are important for ensuring materials are suitable for use in manufacturing pharmaceutical products. The key goal of material management is to source high quality input materials and control their flow through the manufacturing process to deliver quality finished products on time.
1. Quality Risk Management (QRM) is a systematic process that organizes information to support risk-based decisions. It involves identifying hazards, analyzing risks associated with hazards, and managing risks.
2. Several tools can be used for risk analysis including Failure Mode and Effects Analysis (FMEA) which analyzes potential risks and their effects. Risk is evaluated by considering severity, probability of occurrence, detection, and calculating a Risk Priority Number (RPN).
3. Appropriate control measures should be identified to reduce risks to an acceptable level. Residual risk after controls is implemented should be re-evaluated.
The document discusses the results of a study on the impact of COVID-19 lockdowns on air pollution. Researchers analyzed data from dozens of countries and found that lockdowns led to an average decline of nearly 30% in nitrogen dioxide levels over cities. However, they also observed that this improvement was temporary and air pollution rebounded once lockdowns were lifted as vehicle traffic increased again. Overall, the study highlights how lockdowns can provide short-term benefits to air quality but sustained changes are needed to maintain those improvements.
The document discusses various quality tools and statistical methods used in investigations. It begins by defining what an investigation is and explaining the purpose of investigations is to find the root cause of issues in order to enhance understanding and drive process improvement. A variety of investigative tools are presented, including flowcharts, brainstorming, cause-and-effect diagrams, boxplots, Pareto charts, and hypothesis testing. Experimental design techniques like factorial designs are also covered as a tool to efficiently determine the effects of multiple factors on outcomes. The document provides examples and explanations of how to apply each of these tools to systematically gather and analyze data during an investigation.
This document provides an overview of cleaning validation. It defines cleaning validation as removing contaminants from equipment to safely reuse. It discusses cleaning mechanisms like solubility and wetting. Common cleaning agents include water, surfactants, solvents, acids, bases and oxidants. Automated cleaning methods are fixed CIP while manual includes soaking, brushing and wiping. Key cleaning parameters are time, temperature, chemistry and flow. The document also covers grouping strategies to select representative items for validation and considering worst cases.
The document discusses quality risk management (ICH Q9) and provides guidance on its goals, expectations, principles, tools, and methodology. The key goals of quality risk management are to prioritize risks based on their potential impact to patient safety, conduct scientific risk assessments, and ensure appropriate quality systems. The level of risk management should be commensurate with the level of risk and have a strong focus on protecting public health. It also outlines various risk management tools that can be used including FMEA, FMECA, HACCP, and provides guidance on how to initiate, conduct, and review a quality risk management process.
This document outlines good documentation practices for cGMP documents. It states that all documents produced by a company may be reviewed by regulatory agencies. It provides guidelines for writing in cGMP documents, such as using blue ink and initialing and dating all entries. It describes types of cGMP documents and proper ways to record information, make corrections, document deviations, and void or recreate records. The overall purpose is to ensure strict documentation rules are followed to maintain compliance with regulatory agencies.
2. The Early Beginning
1. 1900s house-calls
2. Home remedies,
ointments and “miracle
elixirs”
3. Entertainment and music
4. No regulations until 1902
Fig. 1. Animation of ancient medicine show
6/12/2016 2
3. Public Involvement
• 1905 - The Jungle by
Upton Sinclair.
• Exposure of unsanitary
conditions in meat
packing plants.
• Public awareness and
involvement.
• Pure Food and Drug
Act.
• False labeling became
illegal.
Fig. 2. The Jungle by Upton Sinclair
Fig. 3. 1906 Meat processing plant6/12/2016 3
4. 1941 Initiation of GMP
Sulfathiaziole Tablets
• Contaminated with
phenobarbital.
• About - 300 people
died/injured.
• FDA to enforce and
revise manufacturing and
quality control
requirements. Fig. 4 1906 Certificate of Purity signed by
doctor
6/12/2016 4
5. 1941 - GMP is born
• The beginning of modern standards for
good manufacturing practices can be
traced to an incident that began in
December 1940, when the Winthrop
Chemical Company of New York put on
the market sulfathiazole tablets
contaminated with Phenobarbital.
6/12/2016 5
6. 1962 Kefauver-Harris Drug
Amendments
Thalidomide Tragedy
•Thousands of
children born with
birth defects due to
adverse drug
reactions of morning
sickness pill taken by
mothers. Fig 5. Kennedy signing the Kefauver –
Harris Drug Amendments
6/12/2016 6
8. 1976 Medical Device
Amendments
•1972 and 1973 -
Pacemaker failures
reported
•1975 - hearing-Dalkon
Shield intrauterine
device caused
thousands of injuries
Fig.6 President Gerald Ford signs the
Medical Device Amendments6/12/2016 8
9. 1976 Medical Device
Amendments
• Class I, II and III
medical devices –
based on degree of
control necessary to
be safe and effective.
6/12/2016 9
10. 1980 Infant Formula Act
•1978 - major
manufacturer of infant
formula reformulated
two of its soy products
•1979 - Infants
diagnosed with
hypochloremic
metabolic alkalosis.
Fig.8 Parody on Infant Formula Act
6/12/2016 10
11. 1980 Infant Formula Act
• Greater regulatory control over the
formulation and production of infant
formula
• Modification of industry’s and FDA’s
recall procedures
6/12/2016 11
12. History
FOOD AND DRUGS ACT
1. FOOD AND DRUG REGULATIONS
DIVISION 2 : GOOD MANUFACTURING PRACTICES
2. 1900’S- ADULTERATED FOOD
FIRST PURITY LAWS ENACTED
3. 1930’S- SULFANILIMIDE
DRUGS HAD TO BE PROVEN SAFE
4. 1960’S- THALIDOMIDE
DRUGS HAD TO BE PROVEN SAFE AND EFFECTIVE
THROUGH CLINICAL TRIALS
6/12/2016 12
13. GMP Agencies Worldwide Enforcement
• In US :- USFDA : United States Food and
Drug Administration.
• In UK :- MHRA : Medicines and Healthcare
Products Regulatory Agency.
• In Australia :-TGA : Therapeutic Good
Administration.
• In India :-
FDA : The Ministry of Health, Food and
drug Administration.follow Schedule-M
Part of Drug & Cosmetic Act 1945.
6/12/2016 13
15. cGMP Legal Principles
• Current = dynamic
–Standards evolve over time current, to
emphasize that the expectations are
dynamic.
• Good practices
–Minimal standards
–Not “best practices”
• Unless “best” is, in fact, current minimal
6/12/2016 15
16. Objectives GMP Training
Acquire basic knowledge of current
Good Manufacturing Practices
(cGMP).
1. Good Manufacturing Practices.
2. Contamination.
3. General Employee Hygiene.
4. Food Handling Practices.
6/12/2016 16
17. What are GMPs..?
GMP is that part of Quality assurance which
ensures that the products are consistently
manufactured and controlled to the desired
Quality standards appropriate for intended use
"GMP" - A set of principles and procedures
which, followed by manufacturers for
therapeutic goods, helps ensure that the
products manufactured the required quality.
6/12/2016 17
18. Why are cGMPs important?
• GOVERNMENT REQUIREMENT.
• ENSURE QUALITY PRODUCT.
• REDUCE REJECTS, RECALLS.
• SATISFIED CUSTOMERS.
• MAINTAIN MANUFACTURING
CONSISTENCY.
• COMPANY IMAGE AND REPUTATION.
6/12/2016 18
19. Good Manufacturing Practices
DEAL WITH CONTAMINATION:-
•BY PEOPLE
•BY FOOD MATERIALS
•BY PACKAGING MATERIALS
•BY HAZARDOUS MATERIALS
•BY MISCELLANEOUS MATERIALS
6/12/2016 19
20. Hygiene
All employees working in direct contact
with food, food contact surfaces and
food packaging must conform to
hygienic practices. This protects against
food contamination by microorganisms
or unwanted material.
6/12/2016 20
22. Any behavior that could result
in food contamination such as
eating, use of tobacco, chewing
gum or other unhygienic
practices, is not allowed in
manufacturing & packing areas.
How do we prevent
contamination?
6/12/2016 22
23. Hygiene & Communicable Diseases
• Clothing
• Hair
• Personal habits
• Hand washing
• Personal effects
and jewelry.
• Illness and
disease
• Injuries
• Visitors
• Training.
6/12/2016 23
24. Production employees
- Bathe daily.
- No perfume, aftershave, fragrant
creams.
- No jewellery.
- No false nails or nail polish.
- Fingernails should be trimmed short.
- Use metal detectable bandages
covered with gloves.
- No eating, drinking or chewing gum.
6/12/2016 24
25. Clothing
- Everyone must wear pants and
covered sleeves.
- Separate shoes (no open toes or
high heels) are to be worn in the
factory.
- Personal belongings and street
clothing must be stored in locker
rooms.
6/12/2016 25
26. Illness
• Doctor’s certificate on hiring
• Inform your supervisor or HR if you
are ill with symptoms that could
contaminate ingredients or products.
• No medication allowed in factory.
• Ensure that a clean bandage covers
any open wounds.
6/12/2016 26
27. Hand washing
All employees must wash their hands
thoroughly:
• When they enter food handling areas
• Before starting work.
• After handling contaminated materials
• After breaks.
• After using toilet facilities.
6/12/2016 27
28. Personnel
- Do not leave gloves, masks, etc. lying
around while on break or at shift end.
- Crates, boxes, containers or buckets
must not be placed directly on the
floor.
- Store brooms and dust pans at
stations Provided.
6/12/2016 28
29. Product
- Keep hand contact with ingredients
to a minimum.
- Check ingredients for expiration
dates to ensure that fresh
ingredients are used.
- Cooling product should always be
kept covered.
6/12/2016 29
30. Equipment and containers
- Return tools and attachments to
their proper place after use.
- Check product surfaces before
starting equipment. Remove any
foreign objects or dirt.
- Replace brushes that lose bristles.
6/12/2016 30
32. Sales
•NO DISTRIBUTOR … AND NO
IMPORTER SHALL SELL A DRUG
UNLESS IT HAS BEEN FABRICATED,
PACKAGED/LABELED, TESTED, AND
STORED IN ACCORDANCE WITH THE
REQUIREMENTS OF THIS DIVISION.
6/12/2016 32
33. Premises & Equipments
• Permits effective
cleaning.
• Prevents contamination.
• Orderly conditions.
• Good state of repair.
6/12/2016 33
34. LOCATION AND SURROUNDINGS
• Environmentally polluted areas and industrial
activities which produce disagreeable or
obnoxious odour, fumes, excessive soot,
dust, smoke, chemical or biological emissions
and pollutants, and which pose a serious
threat of contaminating food,
• Areas subject to flooding,
• Areas prone to infestations of pests, and
areas where wastes, either solid or liquid,
cannot be removed effectively.
6/12/2016 34
35. Personnel
• Appropriate education, training and
experience.
• Sufficient number of people
• Receive cGMP training
–Initial and continuing training as
relevant to job responsibilities.
6/12/2016 35
36. Sanitation
• Sanitation Program to prevent contamination
• Cleaning procedures for facilities & equipment
• Pest control.
• Environmental monitoring.
• Documented evidence.
• Keep contact surfaces clean and free of
contamination from tools, cords, cleaning
utensils, machine parts, lubricants and paper.
6/12/2016 36
37. Sanitation
• Keep everything off the floor and area clean
and floors swept.
• Work areas should be cleaned regularly
throughout the shift.
• Keep your immediate working area swept or
dust mopped. Wipe or mop up spilled liquids
promptly.
• Scrape the floor around the work area after
completing a job.
• Leave your work area clean at the end of your
shift.
6/12/2016 37
38. Sanitation
• Hygiene
1. Health and eye examinations.
2. Report adverse health conditions.
3. Clothing requirements
• No direct skin contact with product.
• Wash hands.
• No jewelry or excessive makeup.
4. No smoking, eating, drinking, chewing, or
keeping of plants in operations areas.
6/12/2016 38
39. Raw Material Testing
• Each lot or batch of raw material is tested to
–confirm the identity of the raw materials.
–provide assurance that quality of the drug
in dosage form will not be altered by raw
material defects.
–assure that raw materials have the
characteristics that will provide the
desired quantity or yield in
manufacturing process.
6/12/2016 39
40. RM, PM and Finished Product Testing
• Samples of incoming materials are
collected and tested before use.
• Approved test methods and
specifications are used.
• Results must conform to specifications
for release for use or sale.
• Transportation and storage records.
6/12/2016 40
41. Manufacturing Control
• Written procedures are established
and followed.
–Master formulae, manufacturing
order and packaging order.
• Critical processes are validated.
• 2nd person verification of activities.
• Quarantine system.
• Labelling requirements.
6/12/2016 41
42. Manufacturing Control
• Recall Programme
• Self-Inspection Programme
• Ensure compliance with vendors
/contractors.
6/12/2016 42
43. Manufacturing Control (cont’d)
• Validation: the documented act of
demonstrating that any procedure, process,
equipment, material, activity, or system will
consistently lead to the expected results.
–Design Qualification (DQ)
–Installation Qualification (IQ)
–Operational Qualification (OQ)
–Performance Qualification (PQ)
6/12/2016 43
44. Quality Control Department
• Quality Control Responsibilities
–Testing of bulk components prior to
use by production.
–Testing of finished product prior to
release for sale.
–Stability program (in association with
QA).
6/12/2016 44
45. Samples and Stability
• Samples
–Retain samples of each lot of raw
material and finished product for
specified period of time.
• Stability
–Establish the length of time in
which the product meets all
specifications.
–Monitor the drug for this period
of time.
6/12/2016 45
46. Quality Assurance
• Wide-ranging concept
–covers all matters that individually or
collectively influence the quality of a
product.
• Totality of the arrangements
–to ensure that the drug is continuously of
the right quality for the intended use.
• Quality Assurance incorporates GMP
–and also includes product design and
development, with special focus on
process design.
47. Quality Assurance Department
• Quality Assurance Responsibilities
–Ensure cGMP compliance.
–Review batch records, labels.
–Release product, based on QC test results.
–Authorize all master documents and SOPs.
–Training, auditing.
–Handling customer complaints.
–Recall.
6/12/2016 47
48. Key Quality Terms
• CHANGE CONTROL
–Written procedure that describes the
action to be taken if a change is
proposed to facilities, etc. used in
fabrication, packaging, and testing of
drugs or any change that may affect
quality or support system operation.
6/12/2016 48
49. Key Quality Terms
• DEVIATION
–Planned or unplanned temporary
departure from an approved
process, specification or
procedure with the potential to
impact product quality.
6/12/2016 49
50. Records
• Document all cGMP activities.
• Use Good Documentation
Practices (GDP).
• Records must be readily
available.
• Needed to prove activities
were done.
6/12/2016 50
51. Good Documentation Practices
• Documentation must be:
–Permanent (blue ink)
–Legible, clear, concise.
–Accurate.
–Timely.
–Consistent.
–Complete.
6/12/2016 51
52. Our Goals
Safety: Product is free of unwanted side effects
when used appropriately by patient.
Identity: Product exactly matches the labeling
and related documents.
Purity: Product is free from contamination.
Strength: Product has correct concentration,
potency or therapeutic activity of active
ingredient.
Quality: Product meets all standards,
expectations; performs as claimed and product
made consistently.
6/12/2016 52
53. Summary
1. PHARMACEUTICAL INDUSTRY IS REGULATED
BY GMP AND IT MUST BE FOLLOWED.
2. GMP’S ENSURE DRUG PRODUCTS ARE SAFE,
PURE AND EFFECTIVE.
3. QUALITY SHOULD BE BUILT INTO THE
PRODUCT.
4. GMP'S ARE VERY SIMILAR AND ARE REALLY
GOOD COMMON SENSE.
5. GOOD PRACTICES COVER ALL ASPECTS OF
MANUFACTURING ACTIVITIES PRIOR TO
SUPPLY.
6/12/2016 53